Jeffrey (Jeff) Crosbie is the Director of XRV Medical and works on the administrative and financial side of the business. He is currently a lecturer in physics at a university in Ireland and was previously a university academic at several institutions in Melbourne, Australia. Jeff’s research is focused on a novel form of radiation therapy for cancer using synchrotron-generated X-rays. Jeff has also worked professionally as a medical physicist in hospital radiotherapy centres in Australia as well as at hospitals in the UK and Ireland. Jeff has experience in obtaining research grants and in the management of multi-disciplinary and multi-institutional research projects.

David has broad experience that began in academia (Northwestern Univ., Harvard Medical School, Weizmann Institute, NIH). David then worked several years at the FDA in the Center for Drug Evaluation and Research. He was Senior Science Advisor for OPS/CDER. David also has experience in Science Policy in the Washington DC area. David was Director of Clinical Technologies at Pharmacia. Upon acquisition by Pfizer, he became NY Site Head of Clinical Technology and Director of Pfizer Human Health Technologies. David also worked at a small Molecular Diagnostics Company, Gene Express, and still maintains his consulting organization; ITHW, Inc. Since returning to Australia, David has worked at the CSIRO and Monash University. He is now focusing on setting up two new start ups.

Howard is a veterinary radiologist with experience in clinical practice, academia, and industry-based imaging research. Howard has held various industry positions, including serving as the Scientific Director of Imaging and Vice President of Research and Development at CanCog Technologies. Dr. Dobson is widely recognized for his contributions to the veterinary field.

Jon Evans has held senior management and leadership positions across Australian and International Health Care systems and related industries for over 20 years. With a background in psychology and business administration, Jon has operational experience from direct clinical practice through to leading a public health research agency and a large Metropolitan Health Service. Jon has consulted for international health care systems and private industry in system development and improvement, innovation and commercialisation. Jon is the former Director of Health Strategy within the Department of Health, and subsequently the Director of the Office of Health Innovation and Reform on behalf of the Victorian State Government. He was also the Managing Partner of an Australian/US Health Commercialisation company. He currently holds Health Advisory positions with Chinese Provincial Governments, Health Industry Associations and leads the APAC Health Solutions Group assisting health organisations successfully access international markets. Jon is currently Chairman of CEMTAS Australia. Jon brings substantial expertise and experience in healthcare, medical research and the innovation and commercialisation of Intellectual Property.

Edward (Ted) Gastineau is an experienced researcher and entrepreneur specializing in the use of medical imaging and technology for drug development. He is the President and co-founder of ICON Medical Imaging (Beacon Bioscience) a leading specialist CRO in the medical imaging field. Prior to Beacon, Ted co-founded Intelligent Imaging, a research company specializing in bio-medical imaging, which was acquired by Quintiles. Ted has more than 25 years experience in imaging for drug development and has worked closely with industry, the FDA, and academia to establish best practices which are in place today. Ted has held academic positions with the University of Maryland, Johns Hopkins School of Medicine, Cambridge University and the Smithsonian Institution. Ted brings expertise in many areas including; Regulatory Interaction, Business start up, M&A, P&L responsibility, Partnering, Venture Capital, CRO, Licensing, Study Design, Imaging Endpoints, Image Management and Image Analysis. Ted’s recent activities are in the area of ‘Big Data’ for drug development.

Daniele (Daniel) Pelliccia is a physicist and entrepreneur. Daniel became a full-time entrepreneur in 2016 working in ag-tech and data analytics. He also continues his R&D work on medical imaging applications as co-founder of XRV Medical. Daniel is the Founder of Instruments & Data Tools, working at the interface between sensors, analytics and mobile data acquisitions. He is also the Founder of Rubens Technologies; the intelligence system for the fresh fruit industry. Daniel started his career in Europe in quantum information and synchrotron imaging science. In Australia since 2009, Daniel secured federal funding from the ARC to work on x-ray and medical imaging developing the concept of low-dose imaging for soft tissue.

Micah Barnes provides a unique skill set for his technical and computing role at XRV Medical, owing to his qualifications and training in Physics, Electronic Engineering and Medical Physics. Micah uses his skills and experience to solve unique problems that are faced in both the imaging and treatment of cancers with radiation. Micah is passionate about developing new technologies and improving existing ones so that human kind may benefit from them. In addition to his co-founder role with XRV Medical, Micah is a joint Research Associate at the Peter MacCallum Cancer Centre and The University of Wollongong.